Assessing India's Innovation Climate
In 2005 India mostly strengthened their patent laws to meet international norms, with the distinct requirement that new drug products […]
In 2005 India mostly strengthened their patent laws to meet international norms, with the distinct requirement that new drug products […]
I will be opening the Business Matters for Scientists program at Johns Hopkins Carey School of Business on March 6th
Biotechnology Certificate Program at JHU's Carey School of Business Read Post »
Roche has floated an offer to acquire Genentech, a move which has raised a flurry of questions about the sustainability
Roche and Genentech's mating dance — This isn't the first time Read Post »
Browsing around the Biotechnology Industry Organization site late last night, I was surprised to find that BIO’s press release section
Amgen’s got a record of savvy patenting to protect their blockbusters, and they’ve just done it again. A U.S. Federal
The FDA approved 38 drugs through July this year, down 31 percent from 55 approvals for the same period last
I’ve been trying to elucidate Google’s rumored healthcare plans for quite some time now. Google’s plans are outlined in these
Google's healthcare ambitions — the ultimate second opinion Read Post »
The editor-in-chief of the New England Journal of Medicine accused three of the largest drug companies of ‘making a mockery‘
How does Genentech do it? The biotech company focuses on science — not marketing, acquisitions, or patents
There is no difference between meat and milk from cloned livestock and those foods obtained from conventionally bred cattle, according